Get the latest Science News and Discoveries

FDA Investigating Serious Risk of T-cell Malignancy Following BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies

None

Related news:

Personalized Lifestyle Changes Boost Cognition by 74% in People at Risk of Alzheimer's

'Emotional' Elephants Smashed a Car to Protect One of Their Babies

Common Vaginal Bacteria's Taste For Sugar Could Put Pregnancy at Risk